Supra-Iliac Anterior Quadratus Lumborum Block and Pericapsular Nerve Group (PENG) Block for Analgesia After Total Hip Arthroplasty
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Supra-iliac anterior quadratus lumborum block, Pericapsular nerve group block.
- Who it may be relevant to
- Registry conditions: Supra-Iliac Anterior Quadratus Lumborum Block, Pericapsular Nerve Group Block, Analgesia, Total Hip Arthroplasty. Basic parameters: 18 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Randomized Clinical Non-Inferiority Trial Comparing Supra-Iliac Anterior Quadratus Lumborum Block and Pericapsular Nerve Group (PENG) Block for Analgesia After Total Hip Arthroplasty
Overview
This study aims to compare the analgesic efficacy of supra-iliac anterior quadratus lumborum block (SA-QLB) and pericapsular nerve group (PENG) block in patients undergoing total hip arthroplasty (THA).
Detailed description
Total hip arthroplasty (THA) is one of the most common elective orthopedic procedures, performed to restore mobility, alleviate pain and improve quality of life in patients with degenerative hip joint disease. Its rate is projected to further increase with aging of the population worldwide.
Pericapsular nerve group (PENG) block is a fascial block targets periarticular sensory branches derived from the femoral, obturator and accessory obturator nerves innervating the anterior hip capsule.
The ultrasound-guided quadratus lumborum block (QLB) is a regional anesthetic technique with many described approaches: the lateral QL (QL1) block, the posterior QL (QL2) block, and the anterior QL (transmuscular) block.
Interventions
- Other Supra-iliac anterior quadratus lumborum block
Patients will receive a supra-iliac anterior quadratus lumborum block (SA-QLB) using 20mL of bupivacaine 0.25%. - Other Pericapsular nerve group block
Patients will receive an ultrasound-guided pericapsular nerve group (PENG) block using 20mL of bupivacaine 0.25%.
Primary outcome measures
- Degree of pain [Time frame: 12 hours postoperatively]
Secondary outcome measures (5)
- Total morphine consumption [Time frame: 48 hours postoperatively]
- Time to the first rescue analgesia [Time frame: 48 hours postoperatively]
- Time to ambulation [Time frame: Till the first successful mobilization (Up to 4 hours)]
- Length of hospital stay [Time frame: Till discharge from the hospital (Up to 2 weeks)]
- Incidence of adverse events [Time frame: 24 hours postoperatively]
Eligibility criteria
Inclusion criteria
- Age from 18 to 75 years.
- Both sexes.
- American Society of Anesthesiologists (ASA) classification I-III.
- Scheduled for primary elective unilateral total hip arthroplasty (THA) under spinal anesthesia.
Exclusion criteria
- Known allergies to the drugs used.
- Infection at the injection site.
- Bleeding disorders.
- Recognized neuromuscular disorders.
- Opioid addiction or dependence.
- Contraindications to regional anesthesia or peripheral nerve blockade.
- Body mass index (BMI) > 40 kg/m².
- Associated decompensated cardiac, hepatic, respiratory, or renal diseases.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Tanta University — Tanta
Identifiers
NCT: NCT07606794 · 36265PR1/4/26